Pivaloyloxymethyl Butyrate

N/A

Report date: 2022/11/25 17:17:55
NME

Base Information

Drug NamePivaloyloxymethyl Butyrate
Drug Alias NamePivanexAN-9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungMelanomaLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomIndia
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBar Ilan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTitan Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungMelanomaLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A